Compare DNLI & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNLI | BSM |
|---|---|---|
| Founded | 2013 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2017 | 2015 |
| Metric | DNLI | BSM |
|---|---|---|
| Price | $16.98 | $13.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | ★ $32.58 | $13.00 |
| AVG Volume (30 Days) | ★ 1.7M | 459.4K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 8.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | ★ $412,814,000.00 |
| Revenue This Year | N/A | $1.06 |
| Revenue Next Year | $3,973.10 | $10.27 |
| P/E Ratio | ★ N/A | $11.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.57 | $11.78 |
| 52 Week High | $24.35 | $15.60 |
| Indicator | DNLI | BSM |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 40.50 |
| Support Level | $16.66 | $13.35 |
| Resistance Level | $17.85 | $13.60 |
| Average True Range (ATR) | 0.80 | 0.30 |
| MACD | -0.22 | -0.12 |
| Stochastic Oscillator | 3.07 | 4.90 |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.